Sort
25,944 grants matching “neurodegeneration”
Enhanced APOE2 Expression into Brain for Therapeutic Strategy for Alzheimer's Disease
$515,197Jagdish Singh · North Dakota State University · R01 · FY2025 · AG
Slow Outward Currents and Learning In Aging Hippocampus
$515,116John F Disterhoft · Northwestern University At Chicago · R37 · FY2011 · AG
Mechanisms of non-IgE Mast Cell Activation by Environmental Particulates
$515,084Jared Michael Brown · University Of Colorado Denver · R01 · FY2020 · ES
BMAL1/ARNTL plays a critical, non-circadian role in secondary tissue damage after contusive SCI
$515,058Michal Hetman · University Of Louisville · R01 · FY2023 · NS
Brain penetrant Hsp90 inhibitors for Alzheimer's disease
$515,014Yukari Perrella · Yuma Therapeutics Corporation · R42 · FY2015 · AG
BMAL1/ARNTL plays a critical, non-circadian role in secondary tissue damage after contusive SCI
$514,922Michal Hetman · University Of Louisville · R01 · FY2022 · NS
The FMR1 CGG repeat as functional element and therapeutic target in Fragile X associated disorders
$514,882Peter K Todd · Baylor College Of Medicine · P50 · FY2022 · HD
On-Chip Assay for Identifying Candidate Microtubule Binding Drugs to Treat ADRDs
$514,862Stanislav Karsten · Neuroindx Inc. · R43 · FY2024 · AG
Architecture and function of striatal dopamine release machinery
$514,715Pascal Simon Kaeser · Harvard Medical School · R01 · FY2019 · NS
Architecture and function of striatal dopamine release machinery
$514,715Pascal Simon Kaeser · Harvard Medical School · R01 · FY2018 · NS
Architecture and function of striatal dopamine release machinery
$514,715Pascal Simon Kaeser · Harvard Medical School · R01 · FY2017 · NS
Architecture and function of striatal dopamine release machinery
$514,715Pascal Simon Kaeser · Harvard Medical School · R01 · FY2020 · NS
Acquisition of an Optima Analytical Ultracentrifuge
$514,651Edwin Antony · Saint Louis University · S10 · FY2021 · OD
Cell autonomous and non-autonomous mechanisms in Alzheimer's disease and related dementias
$514,600Lisa M. Ellerby · Buck Institute For Research On Aging · P01 · FY2024 · AG
Molecular Pathogenesis of spinocerebellar ataxia type 12
$514,575Pan Li · Johns Hopkins University · R01 · FY2023 · NS
Functional Validation of the CD2AP Susceptibility Network in Alzheimer's Disease
$514,409Joshua M Shulman · Baylor College Of Medicine · R01 · FY2017 · AG
Fluorescent Redox Indicators to Image Oxidative Stress in Alzheimer's Disease
$514,103Huiwang Ai · University Of Virginia · R01 · FY2025 · AG
Superoxide-sensitive radiotracer as a predictive biomarker of Parkinson's disease progression
$513,957Meagan Joy McManus · Children'S Hosp Of Philadelphia · R01 · FY2022 · NS
Essential Function of miR-29 in the Mature Brain
$513,939Mohanish Deshmukh · Univ Of North Carolina Chapel Hill · R01 · FY2021 · AG
Replication mechanism of human prions
$513,792Jiri G. Safar · Case Western Reserve University · R01 · FY2011 · NS
Shotgun Lipidomics and Alterations in Sphingolipidomes in Alzheimer's Diseases
$513,637Xianlin Han · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2010 · AG
Role of Mnbk in Downs Syndrome brain development &aging
$513,515Institute For Basic Res In Dev Disabil · R01 · FY2004 · HD
Time Restricted Eating intervention for Alzheimer's disease (TREAD)
$513,500Paula Alejandra Desplats · University Of California, San Diego · R61 · FY2024 · AG
Tailor-Made Molecular Chaperones to Target Protein Misfolding
$513,463Shu-Ou Shan · California Institute Of Technology · R01 · FY2025 · AG
Neurophysiological Aspects of Vision-based Speed of Processing Cognitive Training in Older Adults with Mild Cognitive Impairment
$513,459Feng Vankee Lin · University Of Rochester · R01 · FY2015 · NR